Digital Acceleration And ‘Broken’ Customer Experience: What Pharma Should Look Out For
Executive Summary
Biopharma experts discuss at a summit core issues around ensuring that fast-paced digital acceleration does not jeopardize the overall experience of healthcare professionals. Clarity about customer needs/behaviors, embracing a fail-fast, learn-fast mindset and measuring customer experience were among the aspects touched upon.
You may also be interested in...
‘Unsavoury’ Practices: Pharma Will Need To Be More Transparent On CME Expenses In India
India’s revised code for marketing practices includes US Sunshine Act-like requirements converging with tax laws and puts the spotlight on continuing medical education initiatives, where pharma will need to display funding/expenditure data on their website. The Pink Sheet talks to experts on the implications and also new requirements on brand reminders and drug samples.
India Compliance Shifts: Pharma’s Marketing Stack Has Big Opportunities For Health-Tech
Pharma may need to reorient its sales and marketing approach in India amid tighter regulatory scrutiny and growing digital adoption by physicians, opening up new opportunities for digital health startups to innovate across the commercialization value chain, indicates a leading venture capital firm.
Pharma's Clinical Ops Digital Maturity: Patient Experience Tools Lag
Digital maturity of clinical operations at several big pharma firms varies significantly with the gap between best-in-class and the industry average narrowest for site selection tools, recruitment capabilities, and automation, a study has indicated. Digital patient experience tools figure among the least mature capabilities.